Lingax 600 Tablet contains Linezolid 600 mg, an oxazolidinone-class antibiotic indicated for the treatment of serious bacterial infections caused by susceptible Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). It is primarily used in the management of complicated skin and soft tissue infections, nosocomial and community-acquired pneumonia, and infections caused by multidrug-resistant organisms. Linezolid exerts its antibacterial effect by inhibiting bacterial protein synthesis through binding to the 23S ribosomal RNA of the 50S subunit, thereby preventing the formation of the initiation complex. Lingax 600 is administered orally, with a recommended dosage of 600 mg every 12 hours, typically for 10 to 14 days, depending on the infection severity and clinical response. It is essential to monitor patients for potential adverse effects such as myelosuppression, peripheral and optic neuropathy, and serotonin syndrome, especially in prolonged therapy or in combination with serotonergic agents. Caution is advised in patients with pre-existing hematologic disorders or those receiving concomitant medications that may interact with Linezolid. Renal or hepatic impairment does not require dosage adjustment, but clinical monitoring is recommended. Lingax 600 should be used under strict medical supervision to ensure efficacy and minimize resistance development.

Dosage & How to Use